Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
5.23
+0.01 (0.19%)
At close: Nov 20, 2024, 4:00 PM
5.31
+0.08 (1.53%)
Pre-market: Nov 21, 2024, 4:04 AM EST
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $356.07 million as of November 21, 2024. Its market cap has decreased by -70.94% in one year.
Market Cap
356.07M
Enterprise Value
124.24M
1-Year Change
-70.94%
Ranking
Category
Stock Price
$5.23
Market Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has decreased from $1.07B to $356.07M, a decrease of -66.70%. That is a compound annual growth rate of -31.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 356.07M | -64.17% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
| Jan 7, 2022 | 1.07B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akebia Therapeutics | 393.82M |
| Larimar Therapeutics | 392.05M |
| Tactile Systems Technology | 385.87M |
| Contineum Therapeutics | 381.12M |
| 4D Molecular Therapeutics | 380.92M |
| ProQR Therapeutics | 374.63M |
| Q32 Bio | 374.31M |
| AirSculpt Technologies | 372.18M |